Past studies have revealed that the severity of esophageal Lugol‐voiding lesions (LVLs) correlates with the risk for the development of ESCC and TP53 mutation in the background mucosa.7, 8, 9, 10. Here, TP53 is linked to esophageal squamous cell carcinoma.